STAAR Surgical Company (STAA)AQR Arbitrage LLC exited its position 915K shares

915K

Prior-quarter shares · no longer reported

Holdings as of

Mar 31, 2026

Filed

May 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors

What came next

1. Jun 9, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On June 8, 2026, the Compensation Committee (the “Committee”) of the Board of Directors of STAAR Surgical Company (the “Company”) approved an increase to the annual base salary of Deborah Andrews, the Company's Interim Co-Chief Executive Officer and Chief Financial Officer from $512,000 to $575,000.”
2. Jun 18, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On June 18, 2026, STAAR Surgical Company (the “Company”) held its 2026 Annual Meeting of Shareholders (the “2026 Annual Meeting”).”
3. Aug 5, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On August 4, 2026, STAAR Surgical Company (the “Company” or “STAAR”) announced that the Company’s Board of Directors (the “Board”) appointed Warren Foust as President and Chief Executive Officer (“CEO”) and new member of the Board, effective August 4, 2026 (the “Effective Date”).”
4. Aug 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
5. Sep 9, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 8, 2026, STAAR Surgical Company (the “Company”) announced that it appointed David Bailey as Chief Commercial Officer, effective that day Since 2010, Mr. Bailey has been the Founder and President of DB Consulting, a Switzerland-based strategic advisory firm providing advice to private equity firms and multinational companies, including the Company, on strategic planning, operational improvement, overall…”

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for STAAR Surgical Company

OQRO holds no insider, Congress, fund or contract record for STAAR Surgical Company dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its STAA page.

How this filing works

• SEC Form 13F

Other disclosures at STAAR Surgical Company

• SEC Form 13F-HRFeb 17, 2026
• SEC Form 13F-HRNov 14, 2025
• SEC Form 4Apr 10, 2025
• SEC Form 4Apr 10, 2025
• SEC Form 4Apr 10, 2025
• SEC Form 4Apr 10, 2025

Everything OQRO holds on this company is on its STAA page.